CoreCap Advisors’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $880 | Sell |
55
-5,779
| -99% | -$92.5K | ﹤0.01% | 2431 |
|
2025
Q1 | $99.7K | Buy |
5,834
+2,401
| +70% | +$41K | ﹤0.01% | 911 |
|
2024
Q4 | $85K | Sell |
3,433
-924
| -21% | -$22.9K | ﹤0.01% | 986 |
|
2024
Q3 | $124K | Sell |
4,357
-3,368
| -44% | -$96K | 0.01% | 832 |
|
2024
Q2 | $204K | Sell |
7,725
-313
| -4% | -$8.26K | 0.02% | 367 |
|
2024
Q1 | $260K | Buy |
8,038
+1,631
| +25% | +$52.7K | 0.01% | 558 |
|
2023
Q4 | $270K | Buy |
6,407
+647
| +11% | +$27.3K | 0.02% | 490 |
|
2023
Q3 | $221K | Sell |
5,760
-9,652
| -63% | -$371K | 0.02% | 481 |
|
2023
Q2 | $292K | Buy |
+15,412
| New | +$292K | 0.02% | 457 |
|